Precision BioSciences names new CFO and COO changes effective August 1, 2026
Precision BioSciences announced the promotion of Alex Kelly to COO and Naresh Tanna to CFO. These changes support the advancement of its gene editing programs PBGENE-HBV and PBGENE-DMD.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day